We, Rutika Lifescience Pvt. Ltd., specialize in contract manufacturing, supplying, trading, and exporting a wide variety of formulations, including tablets and injections. Our product range includes Paracetamol Infusion IP, Diltiazem Injection IP, Enoxaparin Sodium Injection IP, Buscogast Injection, Encixaparin Sodium Injection IP, and more. Since 2017, we conduct our business operations out of Mumbai, Maharashtra, India.
Our Vision and Mission
Our vision is to be a leading global pharmaceutical company, emphasizing ethical practices and pioneering research. Our mission is to offer a diverse range of affordable, high-quality products and services that enhance health and address medical conditions for all of humanity. We aim to establish and maintain our status as a prominent player in the pharmaceutical healthcare sector. Our commitment to continuous improvement fosters success and yields benefits for our team, customers, and the communities we serve. We are dedicated to delivering quality products at highly competitive prices and ensuring total customer satisfaction by fulfilling specific requirements promptly. We guarantee timely delivery for every order placed.
Why Choose Us? Our company embodies compassion and is dedicated to fulfilling the needs of our clients. We assist our esteemed customers in significantly reducing purchasing expenses by identifying optimal supply options from reputable suppliers across the globe. Our team negotiates the most competitive prices while ensuring quality and conducting thorough due diligence, thereby leveraging procurement as a strategic advantage in the face of global competition and the heightened risk of supply chain disruptions. We are progressing towards success with collaboration and support. We are committed to effective cost management and operational efficiency to maintain our global competitiveness. Our focus is on delivering high-quality products in the pharmaceutical, biotechnology, and healthcare sectors, including generic formulations and an ethical range of products.
We specialize in the formulation of Encixaparin Sodium Injection IP, Calgohin Injection, Diltiazem Injection IP, Enoxaparin Sodium Injection IP, Buscogast Injection, and more. Key factors that provide us with a competitive edge include:
- Collaboration in GMP and WHO manufacturing adhering to PIC/S standards
- Extensive experience in the industry
- Expertise in regulatory affairs
- Development of formulations
- Procurement of pharmaceutical APIs, raw materials, and packaging materials
- A diverse array of products approved by the FDA
Our Warehouse
Our spacious warehouse facility enables us to effectively store our products and manage our inventory. The warehouse is methodically organized into distinct sections, allowing us to categories products based on their specifications. This organization facilitates our ability to meet the large and urgent demands of our clients, ensuring the prompt execution of every project. Our spacious, well-built warehouse area aids us in increasing our work productivity and giving our clients the best.
Key Facts of Rutika Lifescience Pvt. Ltd.
Nature of Business
|
Manufacturer, Trader, Supplier, Exporter
|
Location
|
Mumbai, Maharashtra, India
|
Year of Establishment
|
2017
|
GST Number
|
27AAICR6449K1ZR
|
Number of Employees
|
15
|
Manufacturing Brand Name
|
Rutika Lifescience
|
IE Code
|
AAICR6449K
|
Export Percentage
|
90%
|
Banker
|
HDFC Bank, ICICI Bank
|
Number of Production Unit
|
01
|
Modes of Transport
|
By Rail, Road, Ship & Air
|
|
|
|
|